The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Particle Therapy-Global Market Insights and Sales Trends 2024
Synopsis
Particle therapy is a form of external beam radiotherapy using beams of energetic protons, neutrons, or positive ions for cancer treatment. The most common type of particle therapy is proton therapy.
The global Particle Therapy market size is expected to reach US$ 1106.1 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Particle Therapy in various end use industries. The expanding demands from the Pediatric Cancer, Prostate Cancer, Breast Cancer and Lung Cancer, are propelling Particle Therapy market. Proton Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Heavy Ion Therapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Particle Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Particle Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Particle Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Particle Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Particle Therapy covered in this report include Varian Medical Systems, Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., Hitachi, Ltd., Optivus Proton Therapy, Inc., Protom International, Inc. and Advanced Oncotherapy PLC., etc.
The global Particle Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Varian Medical Systems
Ion Beam Applications Sa (IBA)
Mevion Medical Systems, Inc.
Provision Healthcare, LLC
Sumitomo Heavy Industries, Ltd.
Hitachi, Ltd.
Optivus Proton Therapy, Inc.
Protom International, Inc.
Advanced Oncotherapy PLC.
Danfysik A/S
Global Particle Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Particle Therapy market, Segment by Type:
Proton Therapy
Heavy Ion Therapy
Global Particle Therapy market, by Application
Pediatric Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Other Cancers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Particle Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Particle therapy is a form of external beam radiotherapy using beams of energetic protons, neutrons, or positive ions for cancer treatment. The most common type of particle therapy is proton therapy.
The global Particle Therapy market size is expected to reach US$ 1106.1 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Particle Therapy in various end use industries. The expanding demands from the Pediatric Cancer, Prostate Cancer, Breast Cancer and Lung Cancer, are propelling Particle Therapy market. Proton Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Heavy Ion Therapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Particle Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Particle Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Particle Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Particle Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Particle Therapy covered in this report include Varian Medical Systems, Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., Hitachi, Ltd., Optivus Proton Therapy, Inc., Protom International, Inc. and Advanced Oncotherapy PLC., etc.
The global Particle Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Varian Medical Systems
Ion Beam Applications Sa (IBA)
Mevion Medical Systems, Inc.
Provision Healthcare, LLC
Sumitomo Heavy Industries, Ltd.
Hitachi, Ltd.
Optivus Proton Therapy, Inc.
Protom International, Inc.
Advanced Oncotherapy PLC.
Danfysik A/S
Global Particle Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Particle Therapy market, Segment by Type:
Proton Therapy
Heavy Ion Therapy
Global Particle Therapy market, by Application
Pediatric Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Other Cancers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Particle Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Particle Therapy
1.1 Particle Therapy Market Overview
1.1.1 Particle Therapy Product Scope
1.1.2 Particle Therapy Market Status and Outlook
1.2 Global Particle Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Particle Therapy Market Size by Region (2018-2029)
1.4 Global Particle Therapy Historic Market Size by Region (2018-2023)
1.5 Global Particle Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Particle Therapy Market Size (2018-2029)
1.6.1 North America Particle Therapy Market Size (2018-2029)
1.6.2 Europe Particle Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Particle Therapy Market Size (2018-2029)
1.6.4 Latin America Particle Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Particle Therapy Market Size (2018-2029)
2 Particle Therapy Market by Type
2.1 Introduction
2.1.1 Proton Therapy
2.1.2 Heavy Ion Therapy
2.2 Global Particle Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Particle Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Particle Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Particle Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Particle Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Particle Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Particle Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Particle Therapy Revenue Breakdown by Type (2018-2029)
3 Particle Therapy Market Overview by Application
3.1 Introduction
3.1.1 Pediatric Cancer
3.1.2 Prostate Cancer
3.1.3 Breast Cancer
3.1.4 Lung Cancer
3.1.5 Head and Neck Cancer
3.1.6 Other Cancers
3.2 Global Particle Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Particle Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Particle Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Particle Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Particle Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Particle Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Particle Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Particle Therapy Revenue Breakdown by Application (2018-2029)
4 Particle Therapy Competition Analysis by Players
4.1 Global Particle Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Particle Therapy as of 2022)
4.3 Date of Key Players Enter into Particle Therapy Market
4.4 Global Top Players Particle Therapy Headquarters and Area Served
4.5 Key Players Particle Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Particle Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Varian Medical Systems
5.1.1 Varian Medical Systems Profile
5.1.2 Varian Medical Systems Main Business
5.1.3 Varian Medical Systems Particle Therapy Products, Services and Solutions
5.1.4 Varian Medical Systems Particle Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Varian Medical Systems Recent Developments
5.2 Ion Beam Applications Sa (IBA)
5.2.1 Ion Beam Applications Sa (IBA) Profile
5.2.2 Ion Beam Applications Sa (IBA) Main Business
5.2.3 Ion Beam Applications Sa (IBA) Particle Therapy Products, Services and Solutions
5.2.4 Ion Beam Applications Sa (IBA) Particle Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Ion Beam Applications Sa (IBA) Recent Developments
5.3 Mevion Medical Systems, Inc.
5.3.1 Mevion Medical Systems, Inc. Profile
5.3.2 Mevion Medical Systems, Inc. Main Business
5.3.3 Mevion Medical Systems, Inc. Particle Therapy Products, Services and Solutions
5.3.4 Mevion Medical Systems, Inc. Particle Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Provision Healthcare, LLC Recent Developments
5.4 Provision Healthcare, LLC
5.4.1 Provision Healthcare, LLC Profile
5.4.2 Provision Healthcare, LLC Main Business
5.4.3 Provision Healthcare, LLC Particle Therapy Products, Services and Solutions
5.4.4 Provision Healthcare, LLC Particle Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Provision Healthcare, LLC Recent Developments
5.5 Sumitomo Heavy Industries, Ltd.
5.5.1 Sumitomo Heavy Industries, Ltd. Profile
5.5.2 Sumitomo Heavy Industries, Ltd. Main Business
5.5.3 Sumitomo Heavy Industries, Ltd. Particle Therapy Products, Services and Solutions
5.5.4 Sumitomo Heavy Industries, Ltd. Particle Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Sumitomo Heavy Industries, Ltd. Recent Developments
5.6 Hitachi, Ltd.
5.6.1 Hitachi, Ltd. Profile
5.6.2 Hitachi, Ltd. Main Business
5.6.3 Hitachi, Ltd. Particle Therapy Products, Services and Solutions
5.6.4 Hitachi, Ltd. Particle Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Hitachi, Ltd. Recent Developments
5.7 Optivus Proton Therapy, Inc.
5.7.1 Optivus Proton Therapy, Inc. Profile
5.7.2 Optivus Proton Therapy, Inc. Main Business
5.7.3 Optivus Proton Therapy, Inc. Particle Therapy Products, Services and Solutions
5.7.4 Optivus Proton Therapy, Inc. Particle Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Optivus Proton Therapy, Inc. Recent Developments
5.8 Protom International, Inc.
5.8.1 Protom International, Inc. Profile
5.8.2 Protom International, Inc. Main Business
5.8.3 Protom International, Inc. Particle Therapy Products, Services and Solutions
5.8.4 Protom International, Inc. Particle Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Protom International, Inc. Recent Developments
5.9 Advanced Oncotherapy PLC.
5.9.1 Advanced Oncotherapy PLC. Profile
5.9.2 Advanced Oncotherapy PLC. Main Business
5.9.3 Advanced Oncotherapy PLC. Particle Therapy Products, Services and Solutions
5.9.4 Advanced Oncotherapy PLC. Particle Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Advanced Oncotherapy PLC. Recent Developments
5.10 Danfysik A/S
5.10.1 Danfysik A/S Profile
5.10.2 Danfysik A/S Main Business
5.10.3 Danfysik A/S Particle Therapy Products, Services and Solutions
5.10.4 Danfysik A/S Particle Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Danfysik A/S Recent Developments
6 North America
6.1 North America Particle Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Particle Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Particle Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Particle Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Particle Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Particle Therapy Market Dynamics
11.1 Particle Therapy Industry Trends
11.2 Particle Therapy Market Drivers
11.3 Particle Therapy Market Challenges
11.4 Particle Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
